ADAP

Adaptimmune Therapeutics Plc

Halal Rating :
Comfortable
See Details
Last Price $0.59 Last updated:
Market Cap -
7D Change -26.36%
1 Year Change 17.36%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange
Next Earnings Date

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $40.9m $56.69m - $1.11m 0.00% 1.96%
June 30, 2024 $128.23m $60.06m - $526000.0 0.00% 0.88%
March 31, 2024 $5.68m $54.94m - - 0.00% 0.00%

Company Impact

Help us evaluate Adaptimmune Therapeutics Plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates